Literature DB >> 9043035

Novel patterns of p53 abnormality in breast cancer from Taiwan: experience from a low-incidence area.

M A Lou1, S L Tseng, S F Chang, C T Yue, B L Chang, C H Chou, S L Yang, B H Teh, C W Wu, C Y Shen.   

Abstract

Among 114 breast cancers in Taiwan, the prevalence of p53 mutation (22.8%) and p53 accumulation (38.3%) was similar to that in high-incidence areas. However, novel patterns of p53 abnormalities, including unique sites or types of mutation (i.e. an excessive proportion of G:C to A:T transition at CpG site), and accumulation of wild-type p53 either within nuclear or cytoplasmic compartments were noted. These may have relevance to breast cancer in Taiwan, a low-incidence area.

Entities:  

Mesh:

Year:  1997        PMID: 9043035      PMCID: PMC2063343          DOI: 10.1038/bjc.1997.132

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

Review 1.  Frameshift mutation: determinants of specificity.

Authors:  L S Ripley
Journal:  Annu Rev Genet       Date:  1990       Impact factor: 16.830

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 3.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.

Authors:  M C Pike; D V Spicer; L Dahmoush; M F Press
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

4.  A case-control study of breast cancer in Taiwan--a low-incidence area.

Authors:  P S Yang; T L Yang; C L Liu; C W Wu; C Y Shen
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  High rate of concurrent genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients.

Authors:  C Y Shen; M S Ho; S F Chang; M S Yen; H T Ng; E S Huang; C W Wu
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

6.  Database and software for the analysis of mutations in the human p53 gene.

Authors:  N F Cariello; L Cui; C Beroud; T Soussi
Journal:  Cancer Res       Date:  1994-08-15       Impact factor: 12.701

7.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

Authors:  E Speir; R Modali; E S Huang; M B Leon; F Shawl; T Finkel; S E Epstein
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

Review 8.  Potential genotoxicity of chronically elevated nitric oxide: a review.

Authors:  R H Liu; J H Hotchkiss
Journal:  Mutat Res       Date:  1995-06       Impact factor: 2.433

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model.

Authors:  M S Greenblatt; A P Grollman; C C Harris
Journal:  Cancer Res       Date:  1996-05-01       Impact factor: 12.701

View more
  5 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

Authors:  C A Pise-Masison; R Mahieux; H Jiang; M Ashcroft; M Radonovich; J Duvall; C Guillerm; J N Brady
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 3.  Ubc13: the Lys63 ubiquitin chain building machine.

Authors:  Curtis D Hodge; Leo Spyracopoulos; J N Mark Glover
Journal:  Oncotarget       Date:  2016-09-27

4.  Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.

Authors:  Jer-Wei Chang; Wen-Hung Kuo; Chiao-Mei Lin; Wen-Ling Chen; Shih-Hsuan Chan; Meng-Fan Chiu; I-Shou Chang; Shih-Sheng Jiang; Fang-Yu Tsai; Chung-Hsing Chen; Pei-Hsin Huang; King-Jen Chang; Kai-Ti Lin; Sheng-Chieh Lin; Ming-Yang Wang; Yih-Huei Uen; Chi-Wen Tu; Ming-Feng Hou; Shih-Feng Tsai; Chen-Yang Shen; Shiao-Lin Tung; Lu-Hai Wang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

5.  Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade.

Authors:  S L Ding; L F Sheu; J C Yu; T L Yang; B F Chen; F J Leu; C Y Shen
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.